Compare AbCellera Biologics Inc (ABCL) vs SMX Security Matters plc (SMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs SMX Security Matters plc — how do they compare? AbCellera Biologics Inc trades at $10.08 (market cap $2.99B), while SMX Security Matters plc trades at $16 (market cap $17.04M). The key difference: AbCellera Biologics Inc is far larger — about 175.5× SMX Security Matters plc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals.
| ABCL | SMX | |
|---|---|---|
Market Cap | $2.99B | $17.04M |
Sector | Health | Technology |
52-Week High | $9.76 | $103.71K |
52-Week Low | $2.78 | $12.87 |
Enterprise Value | $2.58B | -$14.29M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) surged 34.78% to $9.34, driven by positive Phase 2 trial results for its menopause drug ABCL635. Despite negative net income margins and cash burn, analyst consensus is strongly bullish with a $15.50 price target. The stock shows a bullish technical trend, with support at $8 and resistance at $10, though RSI levels indicate overbought conditions.
The outlook hinges on ABCL635's clinical progress and future revenue potential, but high valuation ratios and persistent losses pose significant risks. Investor sentiment is optimistic due to recent drug trial success, yet the company must demonstrate a path to profitability to justify current market enthusiasm.
SMX trades at $15.77, down 0.19% with a bearish technical signal from moving averages. The company reported significant losses with -$169.18M net income for 2025 and negative ROE of -819.22%, though recent news highlights balance sheet strengthening and commercialization progress in recycled plastics traceability. Cash flow remains dependent on financing activities.
Outlook remains challenged by persistent losses and negative profitability metrics, offset by positioning in the growing recycled plastics verification market. Key risks include execution on commercialization and cash burn. Institutional sentiment appears mixed amid fundamental weakness but potential regulatory tailwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
